nodes	percent_of_prediction	percent_of_DWPC	metapath
Nelfinavir—ABCG2—Leflunomide—systemic scleroderma	0.102	0.135	CbGbCtD
Nelfinavir—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0797	0.105	CbGbCtD
Nelfinavir—SLCO1A2—Prednisone—systemic scleroderma	0.0675	0.0893	CbGbCtD
Nelfinavir—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0633	0.0837	CbGbCtD
Nelfinavir—CYP1A2—Pentoxifylline—systemic scleroderma	0.0443	0.0585	CbGbCtD
Nelfinavir—CYP1A2—Leflunomide—systemic scleroderma	0.0422	0.0559	CbGbCtD
Nelfinavir—ABCB1—Lisinopril—systemic scleroderma	0.0387	0.0512	CbGbCtD
Nelfinavir—CYP2C9—Leflunomide—systemic scleroderma	0.0381	0.0503	CbGbCtD
Nelfinavir—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0351	0.0464	CbGbCtD
Nelfinavir—SLCO1A2—Methotrexate—systemic scleroderma	0.0339	0.0448	CbGbCtD
Nelfinavir—SLCO1B1—Methotrexate—systemic scleroderma	0.032	0.0422	CbGbCtD
Nelfinavir—ABCB1—Captopril—systemic scleroderma	0.029	0.0383	CbGbCtD
Nelfinavir—CYP2D6—Captopril—systemic scleroderma	0.0273	0.0361	CbGbCtD
Nelfinavir—ABCG2—Methotrexate—systemic scleroderma	0.0254	0.0336	CbGbCtD
Nelfinavir—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0228	0.0302	CbGbCtD
Nelfinavir—CYP2C19—Prednisone—systemic scleroderma	0.0226	0.0299	CbGbCtD
Nelfinavir—ABCB1—Prednisone—systemic scleroderma	0.0182	0.0241	CbGbCtD
Nelfinavir—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0137	0.0181	CbGbCtD
Nelfinavir—CYP3A4—Prednisone—systemic scleroderma	0.0109	0.0145	CbGbCtD
Nelfinavir—ABCB1—Methotrexate—systemic scleroderma	0.00915	0.0121	CbGbCtD
Nelfinavir—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000295	0.00121	CcSEcCtD
Nelfinavir—Insomnia—Leflunomide—systemic scleroderma	0.000293	0.0012	CcSEcCtD
Nelfinavir—Abdominal distension—Prednisone—systemic scleroderma	0.000293	0.0012	CcSEcCtD
Nelfinavir—Paraesthesia—Leflunomide—systemic scleroderma	0.000291	0.00119	CcSEcCtD
Nelfinavir—Myalgia—Lisinopril—systemic scleroderma	0.00029	0.00119	CcSEcCtD
Nelfinavir—Arthralgia—Lisinopril—systemic scleroderma	0.00029	0.00119	CcSEcCtD
Nelfinavir—Anxiety—Lisinopril—systemic scleroderma	0.000289	0.00119	CcSEcCtD
Nelfinavir—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000289	0.00119	CcSEcCtD
Nelfinavir—Dyspnoea—Leflunomide—systemic scleroderma	0.000289	0.00119	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000288	0.00118	CcSEcCtD
Nelfinavir—Muscle spasms—Mycophenolate mofetil—systemic scleroderma	0.000287	0.00118	CcSEcCtD
Nelfinavir—Discomfort—Lisinopril—systemic scleroderma	0.000287	0.00118	CcSEcCtD
Nelfinavir—Dyspepsia—Leflunomide—systemic scleroderma	0.000285	0.00117	CcSEcCtD
Nelfinavir—Pancreatitis—Prednisone—systemic scleroderma	0.000285	0.00117	CcSEcCtD
Nelfinavir—Vomiting—Mometasone—systemic scleroderma	0.000285	0.00117	CcSEcCtD
Nelfinavir—Feeling abnormal—Azathioprine—systemic scleroderma	0.000283	0.00116	CcSEcCtD
Nelfinavir—Rash—Mometasone—systemic scleroderma	0.000282	0.00116	CcSEcCtD
Nelfinavir—Asthenia—Captopril—systemic scleroderma	0.000282	0.00116	CcSEcCtD
Nelfinavir—Dermatitis—Mometasone—systemic scleroderma	0.000282	0.00116	CcSEcCtD
Nelfinavir—Decreased appetite—Leflunomide—systemic scleroderma	0.000282	0.00116	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000282	0.00116	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000281	0.00115	CcSEcCtD
Nelfinavir—Headache—Mometasone—systemic scleroderma	0.00028	0.00115	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.00028	0.00115	CcSEcCtD
Nelfinavir—Insomnia—Mycophenolic acid—systemic scleroderma	0.00028	0.00115	CcSEcCtD
Nelfinavir—Oedema—Lisinopril—systemic scleroderma	0.000278	0.00114	CcSEcCtD
Nelfinavir—Pruritus—Captopril—systemic scleroderma	0.000278	0.00114	CcSEcCtD
Nelfinavir—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000278	0.00114	CcSEcCtD
Nelfinavir—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000277	0.00114	CcSEcCtD
Nelfinavir—Pain—Leflunomide—systemic scleroderma	0.000277	0.00114	CcSEcCtD
Nelfinavir—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000276	0.00113	CcSEcCtD
Nelfinavir—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000276	0.00113	CcSEcCtD
Nelfinavir—Somnolence—Mycophenolic acid—systemic scleroderma	0.000275	0.00113	CcSEcCtD
Nelfinavir—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000275	0.00113	CcSEcCtD
Nelfinavir—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000273	0.00112	CcSEcCtD
Nelfinavir—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000272	0.00112	CcSEcCtD
Nelfinavir—Neutropenia—Prednisone—systemic scleroderma	0.000272	0.00112	CcSEcCtD
Nelfinavir—Abdominal pain—Azathioprine—systemic scleroderma	0.000271	0.00111	CcSEcCtD
Nelfinavir—Body temperature increased—Azathioprine—systemic scleroderma	0.000271	0.00111	CcSEcCtD
Nelfinavir—Skin disorder—Lisinopril—systemic scleroderma	0.00027	0.00111	CcSEcCtD
Nelfinavir—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00027	0.00111	CcSEcCtD
Nelfinavir—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000269	0.0011	CcSEcCtD
Nelfinavir—Diarrhoea—Captopril—systemic scleroderma	0.000269	0.0011	CcSEcCtD
Nelfinavir—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000269	0.0011	CcSEcCtD
Nelfinavir—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000268	0.0011	CcSEcCtD
Nelfinavir—Feeling abnormal—Leflunomide—systemic scleroderma	0.000267	0.0011	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000267	0.0011	CcSEcCtD
Nelfinavir—Mood swings—Methotrexate—systemic scleroderma	0.000266	0.00109	CcSEcCtD
Nelfinavir—Nausea—Mometasone—systemic scleroderma	0.000266	0.00109	CcSEcCtD
Nelfinavir—Anorexia—Lisinopril—systemic scleroderma	0.000265	0.00109	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000265	0.00109	CcSEcCtD
Nelfinavir—Pain—Mycophenolic acid—systemic scleroderma	0.000264	0.00108	CcSEcCtD
Nelfinavir—Hyperglycaemia—Prednisone—systemic scleroderma	0.000262	0.00108	CcSEcCtD
Nelfinavir—Dizziness—Captopril—systemic scleroderma	0.00026	0.00107	CcSEcCtD
Nelfinavir—Liver function test abnormal—Methotrexate—systemic scleroderma	0.00026	0.00107	CcSEcCtD
Nelfinavir—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000259	0.00106	CcSEcCtD
Nelfinavir—Urticaria—Leflunomide—systemic scleroderma	0.000257	0.00106	CcSEcCtD
Nelfinavir—Abdominal pain—Leflunomide—systemic scleroderma	0.000256	0.00105	CcSEcCtD
Nelfinavir—Body temperature increased—Leflunomide—systemic scleroderma	0.000256	0.00105	CcSEcCtD
Nelfinavir—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000255	0.00105	CcSEcCtD
Nelfinavir—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000254	0.00104	CcSEcCtD
Nelfinavir—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000254	0.00104	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000254	0.00104	CcSEcCtD
Nelfinavir—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000254	0.00104	CcSEcCtD
Nelfinavir—Hypersensitivity—Azathioprine—systemic scleroderma	0.000253	0.00104	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000253	0.00104	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000253	0.00104	CcSEcCtD
Nelfinavir—Insomnia—Lisinopril—systemic scleroderma	0.000252	0.00103	CcSEcCtD
Nelfinavir—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000251	0.00103	CcSEcCtD
Nelfinavir—Paraesthesia—Lisinopril—systemic scleroderma	0.00025	0.00103	CcSEcCtD
Nelfinavir—Vomiting—Captopril—systemic scleroderma	0.00025	0.00103	CcSEcCtD
Nelfinavir—Dyspnoea—Lisinopril—systemic scleroderma	0.000248	0.00102	CcSEcCtD
Nelfinavir—Rash—Captopril—systemic scleroderma	0.000248	0.00102	CcSEcCtD
Nelfinavir—Dermatitis—Captopril—systemic scleroderma	0.000248	0.00102	CcSEcCtD
Nelfinavir—Somnolence—Lisinopril—systemic scleroderma	0.000248	0.00102	CcSEcCtD
Nelfinavir—Headache—Captopril—systemic scleroderma	0.000246	0.00101	CcSEcCtD
Nelfinavir—Dyspepsia—Lisinopril—systemic scleroderma	0.000245	0.00101	CcSEcCtD
Nelfinavir—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000244	0.001	CcSEcCtD
Nelfinavir—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000244	0.001	CcSEcCtD
Nelfinavir—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000244	0.001	CcSEcCtD
Nelfinavir—Decreased appetite—Lisinopril—systemic scleroderma	0.000242	0.000993	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.00024	0.000986	CcSEcCtD
Nelfinavir—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000239	0.00098	CcSEcCtD
Nelfinavir—Hypersensitivity—Leflunomide—systemic scleroderma	0.000239	0.00098	CcSEcCtD
Nelfinavir—Pancreatitis—Methotrexate—systemic scleroderma	0.000238	0.000978	CcSEcCtD
Nelfinavir—Pain—Lisinopril—systemic scleroderma	0.000238	0.000977	CcSEcCtD
Nelfinavir—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000237	0.000972	CcSEcCtD
Nelfinavir—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000236	0.000968	CcSEcCtD
Nelfinavir—Diarrhoea—Azathioprine—systemic scleroderma	0.000235	0.000963	CcSEcCtD
Nelfinavir—Haemoglobin—Prednisone—systemic scleroderma	0.000234	0.00096	CcSEcCtD
Nelfinavir—Nausea—Captopril—systemic scleroderma	0.000234	0.000958	CcSEcCtD
Nelfinavir—Haemorrhage—Prednisone—systemic scleroderma	0.000233	0.000955	CcSEcCtD
Nelfinavir—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000233	0.000954	CcSEcCtD
Nelfinavir—Asthenia—Leflunomide—systemic scleroderma	0.000232	0.000954	CcSEcCtD
Nelfinavir—Feeling abnormal—Lisinopril—systemic scleroderma	0.000229	0.000941	CcSEcCtD
Nelfinavir—Pruritus—Leflunomide—systemic scleroderma	0.000229	0.000941	CcSEcCtD
Nelfinavir—Connective tissue disorder—Prednisone—systemic scleroderma	0.000229	0.000939	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000228	0.000934	CcSEcCtD
Nelfinavir—Neutropenia—Methotrexate—systemic scleroderma	0.000227	0.000932	CcSEcCtD
Nelfinavir—Dizziness—Azathioprine—systemic scleroderma	0.000227	0.000931	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000222	0.000912	CcSEcCtD
Nelfinavir—Asthenia—Mycophenolic acid—systemic scleroderma	0.000222	0.00091	CcSEcCtD
Nelfinavir—Diarrhoea—Leflunomide—systemic scleroderma	0.000222	0.00091	CcSEcCtD
Nelfinavir—Urticaria—Lisinopril—systemic scleroderma	0.000221	0.000908	CcSEcCtD
Nelfinavir—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000221	0.000905	CcSEcCtD
Nelfinavir—Abdominal pain—Lisinopril—systemic scleroderma	0.00022	0.000903	CcSEcCtD
Nelfinavir—Body temperature increased—Lisinopril—systemic scleroderma	0.00022	0.000903	CcSEcCtD
Nelfinavir—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000219	0.000899	CcSEcCtD
Nelfinavir—Pruritus—Mycophenolic acid—systemic scleroderma	0.000219	0.000897	CcSEcCtD
Nelfinavir—Vomiting—Azathioprine—systemic scleroderma	0.000218	0.000895	CcSEcCtD
Nelfinavir—Pneumonia—Methotrexate—systemic scleroderma	0.000218	0.000894	CcSEcCtD
Nelfinavir—Eye disorder—Prednisone—systemic scleroderma	0.000218	0.000893	CcSEcCtD
Nelfinavir—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000892	CcSEcCtD
Nelfinavir—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000217	0.00089	CcSEcCtD
Nelfinavir—Rash—Azathioprine—systemic scleroderma	0.000216	0.000888	CcSEcCtD
Nelfinavir—Dermatitis—Azathioprine—systemic scleroderma	0.000216	0.000887	CcSEcCtD
Nelfinavir—Headache—Azathioprine—systemic scleroderma	0.000215	0.000882	CcSEcCtD
Nelfinavir—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000215	0.000881	CcSEcCtD
Nelfinavir—Dizziness—Leflunomide—systemic scleroderma	0.000214	0.000879	CcSEcCtD
Nelfinavir—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000212	0.00087	CcSEcCtD
Nelfinavir—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000211	0.000868	CcSEcCtD
Nelfinavir—Stomatitis—Methotrexate—systemic scleroderma	0.000211	0.000867	CcSEcCtD
Nelfinavir—Angiopathy—Prednisone—systemic scleroderma	0.000211	0.000867	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000211	0.000864	CcSEcCtD
Nelfinavir—Immune system disorder—Prednisone—systemic scleroderma	0.00021	0.000863	CcSEcCtD
Nelfinavir—Pain—Mycophenolate mofetil—systemic scleroderma	0.000209	0.000856	CcSEcCtD
Nelfinavir—Sweating—Methotrexate—systemic scleroderma	0.000208	0.000852	CcSEcCtD
Nelfinavir—Vomiting—Leflunomide—systemic scleroderma	0.000206	0.000845	CcSEcCtD
Nelfinavir—Hypersensitivity—Lisinopril—systemic scleroderma	0.000205	0.000842	CcSEcCtD
Nelfinavir—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000205	0.000841	CcSEcCtD
Nelfinavir—Dizziness—Mycophenolic acid—systemic scleroderma	0.000204	0.000839	CcSEcCtD
Nelfinavir—Epistaxis—Methotrexate—systemic scleroderma	0.000204	0.000839	CcSEcCtD
Nelfinavir—Rash—Leflunomide—systemic scleroderma	0.000204	0.000838	CcSEcCtD
Nelfinavir—Dermatitis—Leflunomide—systemic scleroderma	0.000204	0.000838	CcSEcCtD
Nelfinavir—Nausea—Azathioprine—systemic scleroderma	0.000204	0.000836	CcSEcCtD
Nelfinavir—Headache—Leflunomide—systemic scleroderma	0.000203	0.000833	CcSEcCtD
Nelfinavir—Malnutrition—Prednisone—systemic scleroderma	0.000203	0.000831	CcSEcCtD
Nelfinavir—Erythema—Prednisone—systemic scleroderma	0.000203	0.000831	CcSEcCtD
Nelfinavir—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000825	CcSEcCtD
Nelfinavir—Asthenia—Lisinopril—systemic scleroderma	0.0002	0.00082	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000199	0.000819	CcSEcCtD
Nelfinavir—Pruritus—Lisinopril—systemic scleroderma	0.000197	0.000808	CcSEcCtD
Nelfinavir—Vomiting—Mycophenolic acid—systemic scleroderma	0.000197	0.000806	CcSEcCtD
Nelfinavir—Haemoglobin—Methotrexate—systemic scleroderma	0.000195	0.000802	CcSEcCtD
Nelfinavir—Rash—Mycophenolic acid—systemic scleroderma	0.000195	0.0008	CcSEcCtD
Nelfinavir—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000195	0.000799	CcSEcCtD
Nelfinavir—Hepatitis—Methotrexate—systemic scleroderma	0.000195	0.000798	CcSEcCtD
Nelfinavir—Haemorrhage—Methotrexate—systemic scleroderma	0.000195	0.000798	CcSEcCtD
Nelfinavir—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000795	CcSEcCtD
Nelfinavir—Headache—Mycophenolic acid—systemic scleroderma	0.000194	0.000795	CcSEcCtD
Nelfinavir—Pharyngitis—Methotrexate—systemic scleroderma	0.000193	0.000792	CcSEcCtD
Nelfinavir—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000791	CcSEcCtD
Nelfinavir—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000193	0.000791	CcSEcCtD
Nelfinavir—Nausea—Leflunomide—systemic scleroderma	0.000192	0.00079	CcSEcCtD
Nelfinavir—Diarrhoea—Lisinopril—systemic scleroderma	0.00019	0.000782	CcSEcCtD
Nelfinavir—Ill-defined disorder—Prednisone—systemic scleroderma	0.000188	0.000771	CcSEcCtD
Nelfinavir—Anaemia—Prednisone—systemic scleroderma	0.000187	0.000768	CcSEcCtD
Nelfinavir—Agitation—Prednisone—systemic scleroderma	0.000186	0.000764	CcSEcCtD
Nelfinavir—Dizziness—Lisinopril—systemic scleroderma	0.000184	0.000755	CcSEcCtD
Nelfinavir—Erythema multiforme—Methotrexate—systemic scleroderma	0.000184	0.000755	CcSEcCtD
Nelfinavir—Nausea—Mycophenolic acid—systemic scleroderma	0.000184	0.000753	CcSEcCtD
Nelfinavir—Malaise—Prednisone—systemic scleroderma	0.000183	0.00075	CcSEcCtD
Nelfinavir—Eye disorder—Methotrexate—systemic scleroderma	0.000182	0.000746	CcSEcCtD
Nelfinavir—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000738	CcSEcCtD
Nelfinavir—Vomiting—Lisinopril—systemic scleroderma	0.000177	0.000726	CcSEcCtD
Nelfinavir—Angiopathy—Methotrexate—systemic scleroderma	0.000176	0.000724	CcSEcCtD
Nelfinavir—Immune system disorder—Methotrexate—systemic scleroderma	0.000176	0.000721	CcSEcCtD
Nelfinavir—Rash—Lisinopril—systemic scleroderma	0.000176	0.00072	CcSEcCtD
Nelfinavir—Convulsion—Prednisone—systemic scleroderma	0.000176	0.00072	CcSEcCtD
Nelfinavir—Dermatitis—Lisinopril—systemic scleroderma	0.000175	0.00072	CcSEcCtD
Nelfinavir—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000718	CcSEcCtD
Nelfinavir—Headache—Lisinopril—systemic scleroderma	0.000174	0.000716	CcSEcCtD
Nelfinavir—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000173	0.000708	CcSEcCtD
Nelfinavir—Arthralgia—Prednisone—systemic scleroderma	0.000172	0.000708	CcSEcCtD
Nelfinavir—Myalgia—Prednisone—systemic scleroderma	0.000172	0.000708	CcSEcCtD
Nelfinavir—Anxiety—Prednisone—systemic scleroderma	0.000172	0.000705	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000171	0.000703	CcSEcCtD
Nelfinavir—Discomfort—Prednisone—systemic scleroderma	0.00017	0.000699	CcSEcCtD
Nelfinavir—Malnutrition—Methotrexate—systemic scleroderma	0.000169	0.000695	CcSEcCtD
Nelfinavir—Erythema—Methotrexate—systemic scleroderma	0.000169	0.000695	CcSEcCtD
Nelfinavir—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000685	CcSEcCtD
Nelfinavir—Nausea—Lisinopril—systemic scleroderma	0.000165	0.000679	CcSEcCtD
Nelfinavir—Oedema—Prednisone—systemic scleroderma	0.000165	0.000679	CcSEcCtD
Nelfinavir—Back pain—Methotrexate—systemic scleroderma	0.000164	0.000672	CcSEcCtD
Nelfinavir—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000662	CcSEcCtD
Nelfinavir—Skin disorder—Prednisone—systemic scleroderma	0.000161	0.000659	CcSEcCtD
Nelfinavir—Hyperhidrosis—Prednisone—systemic scleroderma	0.00016	0.000656	CcSEcCtD
Nelfinavir—Anorexia—Prednisone—systemic scleroderma	0.000158	0.000647	CcSEcCtD
Nelfinavir—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000157	0.000645	CcSEcCtD
Nelfinavir—Anaemia—Methotrexate—systemic scleroderma	0.000156	0.000642	CcSEcCtD
Nelfinavir—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000636	CcSEcCtD
Nelfinavir—Rash—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000631	CcSEcCtD
Nelfinavir—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000631	CcSEcCtD
Nelfinavir—Headache—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000627	CcSEcCtD
Nelfinavir—Malaise—Methotrexate—systemic scleroderma	0.000153	0.000627	CcSEcCtD
Nelfinavir—Leukopenia—Methotrexate—systemic scleroderma	0.000152	0.000622	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000151	0.000618	CcSEcCtD
Nelfinavir—Insomnia—Prednisone—systemic scleroderma	0.00015	0.000614	CcSEcCtD
Nelfinavir—Paraesthesia—Prednisone—systemic scleroderma	0.000148	0.000609	CcSEcCtD
Nelfinavir—Convulsion—Methotrexate—systemic scleroderma	0.000147	0.000602	CcSEcCtD
Nelfinavir—Dyspepsia—Prednisone—systemic scleroderma	0.000146	0.000597	CcSEcCtD
Nelfinavir—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000595	CcSEcCtD
Nelfinavir—Arthralgia—Methotrexate—systemic scleroderma	0.000144	0.000592	CcSEcCtD
Nelfinavir—Myalgia—Methotrexate—systemic scleroderma	0.000144	0.000592	CcSEcCtD
Nelfinavir—Decreased appetite—Prednisone—systemic scleroderma	0.000144	0.00059	CcSEcCtD
Nelfinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000143	0.000587	CcSEcCtD
Nelfinavir—Discomfort—Methotrexate—systemic scleroderma	0.000142	0.000584	CcSEcCtD
Nelfinavir—Feeling abnormal—Prednisone—systemic scleroderma	0.000136	0.000559	CcSEcCtD
Nelfinavir—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000135	0.000555	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000135	0.000555	CcSEcCtD
Nelfinavir—Skin disorder—Methotrexate—systemic scleroderma	0.000134	0.000551	CcSEcCtD
Nelfinavir—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000134	0.000548	CcSEcCtD
Nelfinavir—Anorexia—Methotrexate—systemic scleroderma	0.000132	0.000541	CcSEcCtD
Nelfinavir—Urticaria—Prednisone—systemic scleroderma	0.000131	0.000539	CcSEcCtD
Nelfinavir—Body temperature increased—Prednisone—systemic scleroderma	0.000131	0.000536	CcSEcCtD
Nelfinavir—Abdominal pain—Prednisone—systemic scleroderma	0.000131	0.000536	CcSEcCtD
Nelfinavir—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000126	0.000517	CcSEcCtD
Nelfinavir—Insomnia—Methotrexate—systemic scleroderma	0.000125	0.000513	CcSEcCtD
Nelfinavir—Paraesthesia—Methotrexate—systemic scleroderma	0.000124	0.000509	CcSEcCtD
Nelfinavir—Dyspnoea—Methotrexate—systemic scleroderma	0.000123	0.000506	CcSEcCtD
Nelfinavir—Somnolence—Methotrexate—systemic scleroderma	0.000123	0.000504	CcSEcCtD
Nelfinavir—Hypersensitivity—Prednisone—systemic scleroderma	0.000122	0.0005	CcSEcCtD
Nelfinavir—Dyspepsia—Methotrexate—systemic scleroderma	0.000122	0.000499	CcSEcCtD
Nelfinavir—Decreased appetite—Methotrexate—systemic scleroderma	0.00012	0.000493	CcSEcCtD
Nelfinavir—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000119	0.00049	CcSEcCtD
Nelfinavir—Asthenia—Prednisone—systemic scleroderma	0.000119	0.000487	CcSEcCtD
Nelfinavir—Pain—Methotrexate—systemic scleroderma	0.000118	0.000485	CcSEcCtD
Nelfinavir—Pruritus—Prednisone—systemic scleroderma	0.000117	0.00048	CcSEcCtD
Nelfinavir—Feeling abnormal—Methotrexate—systemic scleroderma	0.000114	0.000467	CcSEcCtD
Nelfinavir—Diarrhoea—Prednisone—systemic scleroderma	0.000113	0.000464	CcSEcCtD
Nelfinavir—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000113	0.000464	CcSEcCtD
Nelfinavir—Urticaria—Methotrexate—systemic scleroderma	0.00011	0.00045	CcSEcCtD
Nelfinavir—Dizziness—Prednisone—systemic scleroderma	0.000109	0.000449	CcSEcCtD
Nelfinavir—Abdominal pain—Methotrexate—systemic scleroderma	0.000109	0.000448	CcSEcCtD
Nelfinavir—Body temperature increased—Methotrexate—systemic scleroderma	0.000109	0.000448	CcSEcCtD
Nelfinavir—Vomiting—Prednisone—systemic scleroderma	0.000105	0.000431	CcSEcCtD
Nelfinavir—Rash—Prednisone—systemic scleroderma	0.000104	0.000428	CcSEcCtD
Nelfinavir—Dermatitis—Prednisone—systemic scleroderma	0.000104	0.000427	CcSEcCtD
Nelfinavir—Headache—Prednisone—systemic scleroderma	0.000104	0.000425	CcSEcCtD
Nelfinavir—Hypersensitivity—Methotrexate—systemic scleroderma	0.000102	0.000418	CcSEcCtD
Nelfinavir—Asthenia—Methotrexate—systemic scleroderma	9.91e-05	0.000407	CcSEcCtD
Nelfinavir—Nausea—Prednisone—systemic scleroderma	9.82e-05	0.000403	CcSEcCtD
Nelfinavir—Pruritus—Methotrexate—systemic scleroderma	9.78e-05	0.000401	CcSEcCtD
Nelfinavir—Diarrhoea—Methotrexate—systemic scleroderma	9.46e-05	0.000388	CcSEcCtD
Nelfinavir—Dizziness—Methotrexate—systemic scleroderma	9.14e-05	0.000375	CcSEcCtD
Nelfinavir—Vomiting—Methotrexate—systemic scleroderma	8.79e-05	0.000361	CcSEcCtD
Nelfinavir—Rash—Methotrexate—systemic scleroderma	8.71e-05	0.000358	CcSEcCtD
Nelfinavir—Dermatitis—Methotrexate—systemic scleroderma	8.71e-05	0.000357	CcSEcCtD
Nelfinavir—Headache—Methotrexate—systemic scleroderma	8.66e-05	0.000355	CcSEcCtD
Nelfinavir—Nausea—Methotrexate—systemic scleroderma	8.21e-05	0.000337	CcSEcCtD
